Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
    • Transskriptioner
    • AGM Invitations
    • IPOs
  • InderesTV
  • Forum
  • Discovery
  • Om os
    • Fulgte selskaber
    • Team

SyntheticMR

0,95 SEK

-2,86 %

Mindre end 1K følgere

SYNT

Spotlight Stock Market

Medical Equipment & Services

Health Care

Oversigt
Finansielt overblik og estimater
Ejerskab
Dividend
Investorkonsensus
Sammenligne
-2,86 %
+12,00 %
-26,77 %
-23,20 %
-55,23 %
-76,70 %
-96,50 %
-97,77 %
-53,86 %

SyntheticMR is a medical technology company that is active in the development of analysis and imaging methods. The technology is mainly used for magnetic resonance imaging (MRI) in healthcare. The technology is based on a quantification-based method that aims to increase the efficiency and quality of MRI examinations. The company was founded in 2007 and is headquartered in Linköping.

Læs mere
Markedsværdi
85,04 mio. SEK
Aktieomsætning
952 SEK
Omsætning
57,05 mio.
EBIT %
-86,45 %
P/E
-
Udbytteafkast, %
-
Omsætning og EBIT-margin

Omsætning mio.

EBIT-% (adj.)

EPS og udbytte

EPS (adj.)

Udbytte %

Finanskalender
12.5
2026

Delårsrapport Q1'26

27.5
2026

Generalforsamling '26

25.8
2026

Delårsrapport Q2'26

Alle
Selskabsmeddelelser
ViserAlle indholdstyper
Selskabsmeddelelse9.4.2026, 06.01

SyntheticMR AB: SyntheticMR publishes Annual Report for 2025

SyntheticMR
Selskabsmeddelelse7.4.2026, 13.46

Change of date for the Annual General Meeting in SyntheticMR AB (publ)

SyntheticMR
Selskabsmeddelelse11.2.2026, 15.51

SyntheticMR AB: SyntheticMR's rights issue has been registered - conversion of BTA into shares

SyntheticMR

Bliv en del af Inderes community

Gå ikke glip af noget - opret en konto og få alle de mulige fordele

Inderes konto
Følgere og notifikationer om fulgte virksomheder
Analytikerkommentarer og anbefalinger
Værktøj til at sammenligne aktier og andre populære værktøjer
Opret konto
Selskabsmeddelelse6.2.2026, 07.30

SyntheticMR AB: Year-End report January - December 2025

SyntheticMR
Selskabsmeddelelse4.2.2026, 14.16

SyntheticMR AB: SyntheticMR publishes the outcome of the rights issue

SyntheticMR
Pressemeddelelse20.1.2026, 06.19

Today the subscription period commences in SyntheticMR AB's rights issue

SyntheticMR
Selskabsmeddelelse19.1.2026, 12.51

SyntheticMR AB publishes information document regarding the rights issue

SyntheticMR
Selskabsmeddelelse19.1.2026, 07.48

SyntheticMR AB publishes financial guidance ahead of the forthcoming rights issue

SyntheticMR
Pressemeddelelse16.1.2026, 08.15

SyntheticMR AB: Regulatory Approval for ARIA Monitoring Strengthens SyntheticMR's Position with a Broader Neuroimaging Offering

SyntheticMR
Pressemeddelelse15.1.2026, 07.46

SyntheticMR AB announces intention to publish financial guidance ahead of upcoming rights issue

SyntheticMR
Selskabsmeddelelse9.1.2026, 11.08

Report from the extraordinary general meeting in SyntheticMR AB (publ)

SyntheticMR
Selskabsmeddelelse18.12.2025, 08.01

Notice of extra general meeting in SyntheticMR AB (publ)

SyntheticMR
Selskabsmeddelelse17.12.2025, 22.03

SyntheticMR AB resolves on a fully secured rights issue of approximately SEK 32.8 million

SyntheticMR
Selskabsmeddelelse28.11.2025, 07.00

SyntheticMR AB: Interim report July - September 2025

SyntheticMR
Selskabsmeddelelse25.11.2025, 18.07

SyntheticMR AB (publ) postpones the interim report for the third quarter of 2025

SyntheticMR
Selskabsmeddelelse22.11.2025, 14.53

Marcel Warntjes resigns from the Board of Directors of SyntheticMR AB (publ)

SyntheticMR
Pressemeddelelse29.10.2025, 07.50

SyntheticMR AB: Nomination Committee appointed for the 2026 Annual General Meeting in SyntheticMR

SyntheticMR
Selskabsmeddelelse1.9.2025, 06.18

Lena Åredal Assumes Role as CEO of SyntheticMR AB (publ)

SyntheticMR
Selskabsmeddelelse26.8.2025, 06.07

SyntheticMR AB: Interim report April- June 2025

SyntheticMR
Selskabsmeddelelse13.6.2025, 06.56

Lena Åredal Appointed New CEO of SyntheticMR AB (publ)

SyntheticMR
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.